|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3244912 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16700758.2 |
| Date of filing the European patent application | 2016-01-15 | |
| (97) | Date of publication of the European application | 2017-11-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/050804 |
| Date | 2016-01-15 |
| (87) | Number | WO 2016/113404 |
| Date | 2016-07-21 |
| (30) | Number | Date | Country code |
| 15151488 | 2015-01-16 | EP |
| (72) |
BERGMANN, Karin , DE
HINCELIN-MÉRY, Agnès , FR
JAN, Christelle , FR
|
| (73) |
Sanofi-Aventis Deutschland GmbH ,
Brüningstraße 50, 65929 Frankfurt,
DE
|
| (54) | TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS WITH LIXISENATIDE |
| TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS WITH LIXISENATIDE |